Featured Research

from universities, journals, and other organizations

Researchers Discover How Tuberculosis Bacteria Invade Cells

Date:
August 24, 1997
Source:
Washington University School Of Medicine
Summary:
The bacterium that causes tuberculosis uses a surprisingly underhanded trick to invade cells, researchers at Washington University School of Medicine in St. Louis announced Aug. 27. The strategy is clever and effective -- and it may one day prove to be the disease's downfall.

St. Louis, Aug. 22, 1997 -- The bacterium that causes tuberculosis uses a surprisingly underhanded trick to invade cells, researchers at Washington University School of Medicine in St. Louis announced today. The strategy is clever and effective -- and it may one day prove to be the disease's downfall.

Understanding how the bacterium invades cells may be an important first step toward developing a vaccine to prevent tuberculosis, says Jeffrey S. Schorey, Ph.D., an instructor of medicine and lead author of a paper in the August 22, 1997, issue of Science. Although such a vaccine could be developed only after many more years of study, researchers are excited about the new insight into the common and deadly microbe.

"This study helps us understand what's special about this bacterium and what makes it such an effective pathogen," says Eric J. Brown, M.D., co-author of the paper. Brown is a professor of medicine and of cell biology and physiology at the School of Medicine.

Tuberculosis is a growing global menace that kills more people than any other infectious disease. Three million people die from it each year, and as many as one-third of the world's population is infected with Mycobacterium tuberculosis, the bacterium that causes the disease.

Researchers have long known that M. tuberculosis makes its living by preying on macrophages, the immune system warriors that usually consume bacteria. The bacterium enters a macrophage and apparently multiplies until the cell ruptures, releasing more bacteria to attack other macrophages.

Schorey, Brown and colleagues conducted test-tube studies with M. tuberculosis and a few of its close relatives including M. leprae, which causes leprosy, and M. avium, which frequently infects AIDS patients. The researchers found that all three bacteria share a special trick for finding and invading cells. They grab a protein discarded by the immune system and use it to lure the macrophages to their death.

Normally, when a bacterium enters the body, the immune system responds by tagging the bug with certain proteins that alert the macrophages. Any macrophage (literally "big eater") that detects the proteins will attach itself to the intruder and try to consume it.

Tagging a bug requires a highly choreographed interaction of many proteins, including one called C2a. When combined with another protein, C2a forms a potent enzyme that plays a major role in labeling intruders. After the job is done, C2a breaks off from its partner and floats in the blood with no known function.

Humans may have no use for discarded C2a, but it's apparently invaluable for the disease-causing mycobacteria. Schorey's experiments demonstrated that the bacteria grab onto the protein and use it to create a new label that helps bacteria adhere to the macrophage. The protein also seems to work like a pass key that gives the bacteria easy entrance to the cells. The researchers found that adding infinitesimal amounts of the protein to test tubes containing bacteria and macrophages greatly increased the number of infected cells.

Previous studies have described other invasion techniques used by mycobacteria, but the C2a strategy stands out for one major reason: It's used only by the types of mycobacteria that cause disease. "This is why we think C2a is important for the virulence of these bacteria," Schorey says.

The next important step is to find the bacterial molecule that interacts with C2a, Schorey says. He and his colleagues also plan to move beyond test-tube studies to observe mycobacteria in immune-compromised mice.

If researchers can find the molecule that binds to C2a, and if the results of animal studies echo the findings from the test-tube studies, this new invasion mechanism could form the basis for developing a novel vaccine, Schorey says.

###

This research was supported by the National Institutes of Health.


Story Source:

The above story is based on materials provided by Washington University School Of Medicine. Note: Materials may be edited for content and length.


Cite This Page:

Washington University School Of Medicine. "Researchers Discover How Tuberculosis Bacteria Invade Cells." ScienceDaily. ScienceDaily, 24 August 1997. <www.sciencedaily.com/releases/1997/08/970824235231.htm>.
Washington University School Of Medicine. (1997, August 24). Researchers Discover How Tuberculosis Bacteria Invade Cells. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/1997/08/970824235231.htm
Washington University School Of Medicine. "Researchers Discover How Tuberculosis Bacteria Invade Cells." ScienceDaily. www.sciencedaily.com/releases/1997/08/970824235231.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins